Showing results (1-10 of 546) with videos related to
Sort By:
Pageof 55
Expert Opinion on Investigational Drugs|May 2, 2008
Roflumilast: an oral, once-daily selective PDE-4 inhibitor for the management of COPD and asthmaStephen K FieldAntiviral Chemistry & Chemotherapy|November 26, 1999
Human cytomegalovirus: challenges, opportunities and new drug developmentA K FieldThe American Journal of Medicine|December 26, 2001
Underlying mechanisms of respiratory symptoms with esophageal acid when there is no evidence of airway responseS K FieldCanadian Respiratory Journal|June 22, 2000
Gastroesophageal reflux and asthma: can the paradox be explained?S K FieldThe Journal of Asthma : Official Journal of the Association for the Care of Asthma|December 28, 1999
Gastroesophageal reflux and asthma: are they related?S K FieldClinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine|November 16, 2011
Roflumilast, a Novel Phosphodiesterase 4 Inhibitor, for COPD Patients with a History of ExacerbationsStephen K FieldCurrent Opinion in Molecular Therapeutics|November 21, 2001
Oligonucleotides as inhibitors of human immunodeficiency virusA K FieldAnticancer Research|July 1, 1996
Genomic instability in squamous cell carcinoma of the head and neckJ K FieldTherapeutic Advances in Chronic Disease|July 3, 2015
Bedaquiline for the treatment of multidrug-resistant tuberculosis: great promise or disappointment?Stephen K FieldPageof 55